TRexBio has announced the pricing of its initial public offering at $14 per share. The biotechnology company is slated to begin trading on the Nasdaq exchange.

TRexBio Prices IPO at $14 Per Share on Nasdaq
IPOBiotechnologyStock MarketNew Listings

TRexBio has announced the pricing of its initial public offering at $14 per share. The biotechnology company is slated to begin trading on the Nasdaq exchange.